Micro-biosensors overview: Which statements about micro-scale biosensors are accurate in biomedical and analytical applications?

Difficulty: Easy

Correct Answer: All of these

Explanation:


Introduction / Context:
Micro-biosensors combine microfabrication with biochemical recognition to monitor metabolites, ions, or biomarkers in small volumes or in vivo. Their compact size and integrability enable point-of-care testing, implantable monitors, and high-throughput screening.



Given Data / Assumptions:

  • Implantable use requires biocompatibility and miniaturization.
  • Integration on-chip enables multiplexed assays.
  • Mass production reduces cost and enables disposability.


Concept / Approach:
Advances in MEMS, microfluidics, and surface chemistry allow robust, selective sensors on silicon, polymers, or flexible substrates. Disposable formats minimize fouling risks and cross-contamination, while implants provide continuous monitoring (for example, glucose sensors).



Step-by-Step Solution:

Assess each statement against current micro-biosensor capabilities.Recognize that all three are documented in clinical/analytical literature.Conclude that the comprehensive option is correct.


Verification / Alternative check:
Commercial continuous glucose monitors, lab-on-chip analyzers, and disposable strips exemplify implantation, integration, and mass production.



Why Other Options Are Wrong:

“None of these” contradicts established technology.


Common Pitfalls:
Assuming that implantability and disposability are mutually exclusive; different designs serve different use-cases.



Final Answer:
All of these.

Discussion & Comments

No comments yet. Be the first to comment!
Join Discussion